Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines

Published

Journal Article (Review)

© National Comprehensive Cancer Network, Inc. 2017, All rights reserved. The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.

Duke Authors

Cited Authors

  • Benson, AB; D'Angelica, MI; Abbott, DE; Abrams, TA; Alberts, SR; Saenz, DA; Are, C; Brown, DB; Chang, DT; Covey, AM; Hawkins, W; Iyer, R; Jacob, R; Karachristos, A; Kelley, RK; Kim, R; Palta, M; Park, JO; Sahai, V; Schefter, T; Schmidt, C; Sicklick, JK; Singh, G; Sohal, D; Stein, S; Tian, GG; Vauthey, JN; Venook, AP; Zhu, AX; Hoffmann, KG; Darlow, S

Published Date

  • May 1, 2017

Published In

Volume / Issue

  • 15 / 5

Start / End Page

  • 563 - 573

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

International Standard Serial Number (ISSN)

  • 1540-1405

Citation Source

  • Scopus